Roby Zomer

1. ZOMER, Roby (intervjuvanec), BOHANEC, Borut (intervjuvanec), MUROVEC, Jana (intervjuvanec), FLAJŠMAN, Marko (intervjuvanec). S tujo pomočjo do znanja in zdravil. Nedelo. 26. feb. 2017, letn. 23, št. 9, str. 4-5, ilustr. ISSN 1318-7023. [COBISS.SI-ID 8676985]

2. ŽVAR BAŠKOVIČ GANTAR, Barbara, MAJC, Bernarda, NOVAK, Metka, BREZNIK, Barbara, MLINAR, Mateja, PORČNIK, Andrej, BOŠNJAK, Roman, MLAKAR, Jernej, LAH TURNŠEK, Tamara, ZOMER, Roby. Influence of cannabinoids THC and CBD on brain tumor glioblastoma with differentially expressed cannabinoid receptors CB1 and CB2. V: HRASTAR, Barbara (ur.), MLINAR, Mateja (ur.). Abstract book. International Conference Brain Tumors: from bench to clinic, 26. 11. 2019, Ljubljana. [S. l.: s. n., 2019]. Str. 33. [COBISS.SI-ID 5245263]

3. LAH TURNŠEK, Tamara, NOVAK, Metka, PENA ALMIDON, Milagros A., MARINELLI, Oliviero, ŽVAR BAŠKOVIČ GANTAR, Barbara, MAJC, Bernarda, MLINAR, Mateja, BOŠNJAK, Roman, BREZNIK, Barbara, ZOMER, Roby, NABISSI, Massimo. Cannabigerol is a potential therapeutic agent in a novel combined therapy for glioblastoma. Cells. 4 Feb. 2021, vol. 10, [article] 340, str. 1-21, ilustr. ISSN 2073-4409. https://www.mdpi.com/2073-4409/10/2/340, DOI: 10.3390/cells10020340. [COBISS.SI-ID 51007747]

4. LAH TURNŠEK, Tamara, MAJC, Bernarda, NOVAK, Metka, SUŠNIK, Ajda, BREZNIK, Barbara, PORČNIK, Andrej, BOŠNJAK, Roman, SADIKOV, Aleksander, MALAVOLTA, Marta, HALILČEVIĆ, Selma, MLAKAR, Jernej, ZOMER, Roby. The cytotoxic effects of cannabidiol and cannabigerol on glioblastoma stem cells may mostly involve GPR55 and TRPV1 signalling. Cancers. 2022, vol. 14, iss. 23, str. 1-21, ilustr. ISSN 2072-6694. https://doi.org/10.3390/cancers14235918, DiRROS - Digitalni repozitorij raziskovalnih organizacij Slovenije, DOI: 10.3390/cancers14235918. [COBISS.SI-ID 132774659]